Registry Confirms Low Risk of DKA With SGLT2 Inhibitors in Diabetes Registry Confirms Low Risk of DKA With SGLT2 Inhibitors in Diabetes

Danish registry data suggest diabetic ketoacidosis risk is slightly but not significantly elevated among type 2 diabetes patients using the drug class.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news